Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
28.60
-0.07 (-0.24%)
At close: May 14, 2026, 4:00 PM EDT
28.60
0.00 (0.00%)
After-hours: May 14, 2026, 4:16 PM EDT
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $5.29 billion as of May 14, 2026. Its market cap has decreased by -16.35% in one year.
Market Cap
5.29B
Enterprise Value
4.82B
1-Year Change
-16.35%
Ranking
Category
Stock Price
$28.60
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has increased from $4.79B to $5.29B, an increase of 10.52%. That is a compound annual growth rate of 1.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 5.30B | 32.06% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 6.07B |
| PTC Therapeutics | 6.03B |
| Corcept Therapeutics | 6.03B |
| TG Therapeutics | 5.99B |
| Scholar Rock Holding | 5.99B |
| Immunovant | 5.91B |
| Celcuity | 5.91B |
| Cogent Biosciences | 5.84B |